The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival
Open accessAbstract
Murine mAbs reactive with the surface of Mycobacterium tuberculosis were assayed for their ability to affect the course of infection in mice challenged with virulent organisms. An IgG3 mAb (9d8) specific for arabinomannan and reactive with purified antigen from a clinical isolate of M. tuberculosis conferred partial protection on mice after respiratory challenge (30–60% survival >75 days; P ≤ 0.05). Control mice pretreated with an irrelevant mAb of the same isotype succumbed to tuberculosis within 30 days. Mice with gene disruptions in interferon γ and major histocompatibility complex Class II also were partially protected from challenge. The protective mAb was neither bactericidal nor inhibitory of infection or bacterial replication. Nevertheless, it profoundly altered the nature of the granulomas in the infected lungs. Mice treated with mAb 9d8 and challenged with M. tuberculosis localized the pathogen within granuloma centers, suggesting that the mAb conferred protection by enhancing a cellular immune response.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“there is ample evidence that it is possible to generate protective mAbs against many viruses and microorganisms (Teitelbaum et al, 1998; Nosanchuk et al, 2003; Both et al, 2013).”
From mRNA mediates passive vaccination against infectious agents, toxins, and tumors (2017) · cites this paper as Teitelbaum et al, 1998
Citations
Cites
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.
Flynn, J. L., Chan, J., Triebold, K. J., Dalton, D. K., Stewart, T. A., & Bloom, B. R. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.6.2249 · Cited by 2,468
Self-citationDisseminated tuberculosis in interferon gamma gene-disrupted mice.
Cooper, A. M., Dalton, D. K., Stewart, T. A., Griffin, J. P., Russell, D. G., & Orme, I. M. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.6.2243 · Cited by 1,987
Flynn, J. L., Goldstein, M. M., Chan, J., Triebold, K. J., Pfeffer, K., Lowenstein, C. J., Schrelber, R., Mak, T. W., & Bloom, B. R. (1995) · Immunity · doi:10.1016/1074-7613(95)90001-2 · Cited by 1,678
Self-citationSelwyn, P. A., Hartel, D. M., Lewis, V. A., Schoenbaum, E. E., Vermund, S. H., Klein, R. S., Walker, A. T., & FRIEDLAND, G. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903023200901 · Cited by 1,572
Cattoretti, G., Becker, M. H. G., Key, G., Duchrow, M., ter, C. S. ⁄., Galle, J., & Gerdes, J. (1992) · The Journal of Pathology · doi:10.1002/path.1711680404 · Cited by 1,447
Identification of nitric oxide synthase as a protective locus against tuberculosis
MacMicking, J. D., North, R. J., LaCourse, R., Mudgett, J. S., Shah, S. K., & Nathan, C. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5243 · Cited by 1,180
Chan, J., Xing, Y., Magliozzo, R. S., & Bloom, B. R. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.175.4.1111 · Cited by 1,062
Self-citationInterferon-γ –Receptor Deficiency in an Infant with Fatal Bacille Calmette–Guérin Infection
Jouanguy, E., Altare, F., Lamhamedi‐Cherradi, S., Revy, P., Emile, J., Newport, M. J., Levin, M., Blanche, S., Seboun, E., Fischer, A., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352604 · Cited by 892
Flynn, J. L., Goldstein, M. M., Triebold, K. J., Koller, B. H., & Bloom, B. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12013 · Cited by 793
Self-citationArmstrong, J. A., & Hart, P. D. (1975) · The Journal of Experimental Medicine · doi:10.1084/jem.142.1.1 · Cited by 537
Tuberculosis: Pathogenesis, protection, and control
Cock, K. M. D. (1995) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(95)90122-1 · Cited by 416
Schaible, U. E., Sturgill-Koszycki, S., Schlesinger, P. H., & Russell, D. G. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1290 · Cited by 402
Anegón, I., Cuturi, M. C., Trinchieri, G., & PERUSSIA, B. (1988) · The Journal of Experimental Medicine · doi:10.1084/jem.167.2.452 · Cited by 368
IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection
Flynn, J. L., Goldstein, M. M., Triebold, K. J., Sypek, J. P., Wolf, S., & Bloom, B. R. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.5.2515 · Cited by 324
Self-citationThe role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection.
Cooper, A. M., Roberts, A. D., Rhoades, E. R., Callahan, J. E., Getzy, D. M., & Orme, I. M. (1995) · PubMed Central · Cited by 308
Antibody immunity and invasive fungal infections
Casadevall, A. (1995) · Infection and Immunity · doi:10.1128/iai.63.11.4211-4218.1995 · Cited by 282
Self-citationNeutrophils are involved in acute, nonspecific resistance to Listeria monocytogenes in mice
Rogers, H. W., & Unanue, E. R. (1993) · Infection and Immunity · doi:10.1128/iai.61.12.5090-5096.1993 · Cited by 271
Self-citationGlatman‐Freedman, A., & Casadevall, A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.514 · Cited by 214
Self-citationThe production of granulomata by antigen‐antibody complexes
Spector, W. G., & Heesom, N. (1969) · The Journal of Pathology · doi:10.1002/path.1710980105 · Cited by 185
The immunology of antituberculous immunity.
Mackaness, G. B. (1968) · PubMed · doi:10.1164/arrd.1968.97.3.337 · Cited by 157
T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice
Yuan, R., Casadevall, A., Oh, J. S., & Scharff, M. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2483 · Cited by 153
Self-citationFanger, N. A., Voigtlaender, D., Liu, C., Swink, S. L., Wardwell, K., Fisher, J., Graziano, R. F., Pfefferkorn, L. C., & Guyre, P. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.7.3090 · Cited by 147
Mukherjee, J., Casadevall, A., & Scharff, M. D. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.177.4.1105 · Cited by 147
Self-citationEffect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection
Feldmesser, M., & Casadevall, A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.2.790 · Cited by 136
Self-citationAntibody-mediated protection against intracellular pathogens
Casadevall, A. (1998) · Trends in Microbiology · doi:10.1016/s0966-842x(98)01208-6 · Cited by 116
Self-citationAugmentation of naive, Th1 and Th2 effector CD4 Responses by IL-6, IL-1 and TNF
Joseph, S. B., Miner, K. T., & Croft, M. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199801)28:01 · Cited by 100
Self-citationBASIS FOR IMMUNITY TO TYPHOID IN MICE AND THE QUESTION OF “CELLULAR IMMUNITY”
Jenkin, C. R., & Rowley, D. C. (1963) · Bacteriological Reviews · doi:10.1128/br.27.4.391-404.1963 · Cited by 86
Chatterjee, D., Khoo, K., McNeil, M., Dell, A., Morris, H. R., & Brennan, P. J. (1993) · Glycobiology · doi:10.1093/glycob/3.5.497 · Cited by 82
Glatman‐Freedman, A., Martin, J., Riska, P. F., Bloom, B. R., & Casadevall, A. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.11.2795-2802.1996 · Cited by 65
Self-citationMozaffarian, N., Berman, J. W., & Casadevall, A. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.57.4.657 · Cited by 56
Self-citationVossen, A. C. T. M., Tibbe, G. J. M., Kroos, M. J., van de Winkel, J. G. J., Benner, R., & Savelkoul, H. F. J. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250603 · Cited by 42
Bayón, Y., Alonso, A., & Crespo, M. S. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.2.887 · Cited by 38
Vecchiarelli, A., Retini, C., Monari, C., & Casadevall, A. (1998) · Infection and Immunity · doi:10.1128/iai.66.3.1244-1247.1998 · Cited by 38
Self-citationFeldmesser, M., Kress, Y., & Casadevall, A. (1998) · The Journal of Infectious Diseases · doi:10.1086/515314 · Cited by 33
Self-citationMarsh, C. B., Lowe, M. P., Rovin, B. H., Parker, J. M., Liao, Z., Knoell, D. L., & Wewers, M. D. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.8.3942 · Cited by 29
Marsh, C., Lowe, M. P., Rovin, B. H., et al. (1998) · PubMed · Cited by 28
McMichael, A. J. (1995) · Population Studies · doi:10.1080/0032472031000148956 · Cited by 23
Microwave Antigen Retrieval in Citrate Buffer
Swanson, P. E. (1994) · Laboratory Medicine · doi:10.1093/labmed/25.8.520 · Cited by 19
Research works printed but not linked: 3
- A M Cooper, A D Roberts, E R Rhoades, J E Callahan, D M Getzy, I M Orme Immunology 84, 423–432 (1995).
- A M Dannenberg, G A W Rook Tuberculosis: Pathogenesis, Protection and Control, ed B R Bloom (Am. Soc. Microbiol., Washington, DC), pp. 463–465 (1994).
- G B Mackaness, R V Blanden, F M Collins Am Rev Respir Dis 97, 337–344 (1968).
Cited by
Sorted by citations
Flynn, J., & Chan, J. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.93 · Cited by 1,144
How can immunology contribute to the control of tuberculosis?
Kaufmann, S. H. E. (2001) · Nature reviews. Immunology · doi:10.1038/35095558 · Cited by 727
A Functional Role for Antibodies in Tuberculosis
Lu, L. L., Chung, A. W., Rosebrock, T. R., Ghebremichael, M. S., Yu, W., Grace, P. S., Schoen, M. K., Tafesse, F., Martin, C. J., Leung, V. W. Y., et al. (2016) · Cell · doi:10.1016/j.cell.2016.08.072 · Cited by 560
Passive antibody therapy for infectious diseases
Casadevall, A., Dadachova, E., & Pirofski, L. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro974 · Cited by 542
Self-citationThe heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination
Pethe, K., Alonso, S., Biet, F., Delogu, G., Brennan, M. J., Locht, C., & Menozzi, F. D. (2001) · Nature · doi:10.1038/35084083 · Cited by 462
Metadata
- Authors
- Teitelbaum, R., Glatman-Freedman, A., Chen, B., Robbins, J. B., Unanue, E., Casadevall, A., & Bloom, B. R.
- Affiliations
- National Institutes of Health (US)
- Howard Hughes Medical Institute and the Department of Microbiology and Immunology of the Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10064; Department of Pediatrics, Jacobi Medical Center, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892; and Department of Pathology, Washington University, St. Louis, MO 63110
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1998-12-22
- Volume
- 95
- Issue
- 26
- Pages
- 15688-15693
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC28105
- OpenAlex
- W2080781566
- Cited by
- 275
- References
- 39
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 10 · 2023: 14 · 2022: 5 · 2021: 6 · 2020: 6 · 2019: 12 · 2018: 11 · 2017: 8 · 2016: 10 · 2015: 11 · 2014: 11 · 2013: 13 · 2012: 13
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- National Institutes of Health (5r01hl059842-23, 5r37ai033142-24)
- National Heart, Lung, and Blood Institute (R01-HL059842)
- National Institute of Allergy and Infectious Diseases (AI-07118, AI 33142, R01AI007118, R01AI033142, R37-AI033142)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- Mycobacterium tuberculosis, monoclonal antibodies, arabinomannan, surface antigens, protective immunity, granuloma formation, interferon-gamma, MHC class II, cell-mediated immunity, respiratory challenge, antibody-mediated protection
- MeSH terms
- Animals, Antibodies, Monoclonal, Antibody Specificity, Antigens, Bacterial, Antigens, Surface, Female, Genes, MHC Class II, Granuloma, Interferon-gamma, Lung, Mannans, Mice, Inbred BALB C, Mice, Inbred C57BL, Mycobacterium tuberculosis, Neutrophils, Tuberculosis, Virulence, Survival Rate, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review